This inventor holds 3 USPTO granted patents. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1980
Title: The Innovations of Pacifico A Principe
Introduction
Pacifico A Principe is a notable inventor based in South River, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance the effectiveness of antibiotics. With a total of 3 patents to his name, Principe's work has had a meaningful impact on medical treatments.
Latest Patents
One of his latest patents is the .beta.-Lactamase inhibitor EM4615. This substance inhibits the enzyme .beta.-lactamase, which is produced by a wide range of microorganisms. EM4615 is obtained when species of the microorganism Micromonospora are cultivated under aerobic fermentation conditions. The inhibitor can be isolated from the fermentation medium by extraction. This substance is particularly useful in enhancing the effectiveness of .beta.-lactam antibiotics such as penicillins and cephalosporins. Another significant patent involves fluorene-2-acetic acids and their derivatives. This patent discloses fluorene-2-glyoxylic acid, 7-substituted derivatives, and ester derivatives as useful for treating inflammatory conditions.
Career Highlights
Pacifico A Principe is associated with E. R. Squibb Sons, Inc., where he has contributed to various innovative projects. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
He has collaborated with notable colleagues, including Eric T Stiller and Seymour D Levine, to further enhance the scope of his inventions.
Conclusion
Pacifico A Principe's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
